Tissue distribution and chemical induction of multiple drug resistance genes in rats

Drug Metabolism and Disposition

Volumn 30, Issue 7, 2002, Pages 838-844

  Brady, James M ^a   Cherrington, Nathan J ^b   Hartley, Dylan P ^a   Buist, Susan C ^b   Li, Ning ^a   Klaassen, Curtis D ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA CYANOPREGNENOLONE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ACETYLSALICYLIC ACID; ALLYL SULFIDE; ANTINEOPLASTIC AGENT; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; CLOFIBRATE; DEXAMETHASONE; ETHOXYQUIN; FLAVONE DERIVATIVE; ISONIAZID; MULTIDRUG RESISTANCE PROTEIN; OLTIPRAZ; PERFLUORODECANOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENOBARBITAL; PHTHALIC ACID DERIVATIVE; POLYCHLORINATED BIPHENYL; PREGNANE X RECEPTOR; PROTEIN MDR1A; PROTEIN MDR1B; SPIRONOLACTONE; STREPTOZOCIN; UNCLASSIFIED DRUG; XENOBIOTIC AGENT; GLYCOPROTEIN P; ORGANIC COMPOUND;

ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG METABOLISM; DRUG TRANSPORT; ENZYME INDUCTION; FEMALE; GASTROINTESTINAL TRACT; GENE INDUCTION; GENE LOCATION; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSCRIPTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REGULATORY MECHANISM; RNA ISOLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION REGULATION; MULTIDRUG RESISTANCE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMAL; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION REGULATION; MALE; ORGANIC CHEMICALS; P-GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TISSUE DISTRIBUTION; ANIMALS;

ANIMALIA;

EID: 0035987894     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.7.838     Document Type: Article

References (39)

1. Cloning and regulation of the rat mdr2 gene
2. Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics
3. Organ distribution of multidrug resistance proteins 1, 2, and 3 (MRPI, 2 and 3) mRNA and hepatic induction of MRP3 by constitutive androstane receptor (CAR) activators in rats
4. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-I protease inhibitors into brain and testes
5. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues
6. Peptide mimetic HIV protease inhibitors are ligands for the orphan receptor SXR
7. P-glycoprotein expression in human, mouse, hamster and rat hepatocytes in primary culture
8. Molecular biology of drug resistance
9. P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs
10. The effect of rifampin treatment on intestinal expression of human MRP transporters
11. Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P4501A gene family expression in primary hepatocyte cultures and rat liver
12. Nuclear receptor response elements mediate induction of intestinal mdr1 by rifampin
13. The sister of P-glycoprotein represents the canalicular Bile Salt Export Pump of mammalian liver
14. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
15. Detection of chemical-induced differential expression of rat hepatic cytochrome P450 mRNA transcripts using branched DNA signal amplification technology
16. Physiologically based pharmacokinetics of digoxin in mdr1a knockout mice
17. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
18. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein
19. The biology of the P-glycoproteins
20. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice
21. Induction of cytochrome P450 (CYP)1A1, CYP1A2 and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes
22. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers
23. Functional characterization of the rat mdr1b encoded P-glycoprotein: Not all inducing agents are substrates
24. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A
25. Phenotypic variability in induction of P-glycoprotein mRNA by aromatic hydrocarbons in primary human hepatocytes
26. P-glycoprotein: A major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans
27. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately upregulate these proteins in human colon carcinoma cells
28. Modulation of MDR1 and CYP3A expression by dexamethasone: Evidence for an inverse regulation in adrenals
29. Homozygous disruption of the murine mdr2 p-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
30. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure
31. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
32. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
33. The orphan nuclear receptor SRX coordinatley regulates drug metabolism and efflux
34. Murine mdr-1, mdr-2 and mdr-3 gene expression: No coinduction with the Cyp1a-1 and Nmo-1 genes in liver by 2, 3, 7, 8-tetra-chlorodibenzo-p-dioxin
35. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier
36. Multidrug resistance gene family and chemical carcinogens
37. Expression of a full-length cDNA for the human "MDRI" gene confers resistance to colchicine, doxorubicin and vinblastine
38. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells
39. Morphine antinociception is enhanced in mdr1a gene-deficient mice